1. Fowler KB, Stagno S, Pass RF. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA. 2003. 289:1008–1011.
Article
2. Yamamoto AY, Figueiredo LT, Mussi-Pinhata MM. [Prevalence and clinical aspects of congenital cytomegalovirus infection]. J Pediatr (Rio J). 1999. 75:23–28.
Article
3. Numazaki K, Fujikawa T. Chronological changes of incidence and prognosis of children with asymptomatic congenital cytomegalovirus infection in Sapporo, Japan. BMC Infect Dis. 2004. 4:22.
Article
4. van der Sande MA, Kaye S, Miles DJ, Waight P, Jeffries DJ, Ojuola OO, et al. Risk factors for and clinical outcome of congenital cytomegalovirus infection in a Peri-Urban West-African Birth Cohort. PLoS ONE. 2007. 2:e492.
Article
5. Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr. 1997. 130:624–630.
Article
6. Kimberlin DW, Lin CY, Sánchez PJ, Demmler GJ, Dankner W, Shelton M, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003. 143:16–25.
7. Schlesinger Y, Halle D, Eidelman AI, Reich D, Dayan D, Rudensky B, et al. Urine polymerase chain reaction as a screening tool for the detection of congenital cytomegalovirus infection. Arch Dis Child Fetal Neonatal Ed. 2003. 88:F371–F374.
Article
8. Espy MJ, Uhl JR, Sloan LM, Buckwalter SP, Jones MF, Vetter EA, et al. Real-time PCR in clinical nicrobiology: applications for routine laboratory testing. Clin Microbiol Rev. 2006. 19:165–256.
Article
9. Ivarsson SA, Lernmark B, Svanberg L. Ten-year clinical, developmental, and intellectual follow-up of children with congenital cytomegalovirus infection without neurologic symptoms at one year of age. Pediatrics. 1997. 99:800–803.